Upcoming Medical Conferences in WhistlerSearch Criteria : Canada Whistler
Feb 10 - 13, 2020 | MOC 19.50 | USD $999 | Whistler, British Columbia
2020 Canadian Critical Care Conference (CCCC) is organized by Canadian Critical Care Conference (CCCC) and will be held from Feb 10 - 13, 2020 at Hotel Fairmont Château Whistler, Whistler, British Columbia, Canada. This conference is accredited for 19.5 MOC Section 1 study credits with the Royal College through University of British Columbia. It is also accredited by AACME and the JFICM. Description: The conference promotes excellence and addresses the challenge of providing appropriate care in the most effective and efficient manner to the critically ill patient. Additional details will be posted as soon as they are available.
Feb 14 - 16, 2020 | Credits 12.00 | Whistler, British Columbia
Pediatric and Adult Infectious Diseases for Primary Care is organized by MCE Conferences, Inc. and will be held from Feb 14 - 16, 2020 at Fairmont Chateau Whistler, Whistler, British Columbia, Canada. Target Audience: All Physicians and other Healthcare Professionals seeking clinical information about issues in Pediatric and Adult Infectious Diseases Accreditation: This live activity is being reviewed and will be acceptable for up to 12 Prescribed credits by the American Academy of Family Physicians. AAFP Prescribed credit is accepted by the American Medical Association as equivalent to the AMA PRA Category 1 credit toward the AMA Physicians Recognition Award. Physicians should only claim credit commensurate with the extent of their participation in the activity. Overview: This conference is designed to provide primary care practitioners with up-to-date, evidence-based information on commonly encountered issues in Pediatric and Adult Infectious Diseases, while suggesting pragmatic approaches to clinical management. The discussion-based format of the conference will encourage audience participation through dynamic lectures, case-based studies, and hands-on workshops. Keynote speakers will present and critically assess recent advancements and industry updates in Pediatric and Adult Infectious Diseases, with the goal of enhancing the knowledge-base and core competence of attendees. The successful completion of this interactive program diagnosing, treating, and prescribing the most effective courses of treatment, with the ultimate goal of improving patient outcomes. Topics and Objectives: Day 1: Community-Acquired Respiratory Infections in Adults with an Emphasis on Objectives: 1) Recognize when to prescribe antibiotics for adults with respiratory infections 2) Familiarize with risk assessment and treatment algorithms for community-acquired pneumonia in adults 3) familiarized with non-culture diagnostic tests for pneumonia and when to use them Infectious Gastroenteritis Syndromes and Food-Borne Illnesses Objectives: 1) Know the epidemiology of gastroenteritis in adults 2) Learn the differential diagnosis, evaluation, and management of infectious diarrhea in adults 3) Be able to counsel patients about food borne illness and how to prevent them Rules of Immunity: Considering Primary Immunodeficiencies in the Outpatient Setting Objectives: 1) Identify the most common causes of primary immunodeficiency in children; 2) Recognize the most common ‘red flags’ for consideration of immune deficiency Herpes are Like Diamonds: They’re Forever Objectives: 1) Recognize the common presentations, diagnosis, and management of a) EBV, b) CMV, and c) HSV in children Day 2: What’s All the Pus About? Staphylococcal and Streptococcal Infections Objectives: 1) Plan appropriate management strategies for skin and soft tissue infections due to S. aureus and S. pyogenes; 2) Identify suppurative and non-suppurative complications of streptococcal infections; 3) Plan appropriate therapy for recurrent skin and soft tissue infections Pain in the Neck: Approach to Children with Lymphadenopathy Objectives: 1) Recognize the common causes of lymphadenopathy in children; 2) Plan a management course for common causes of adenopathy Urinary Tract Infections Objectives: 1) Learn to use diagnostic algorithms, and diagnose different urinary tract infection syndromes 2) familiarized with management guidelines for UTI and asymptomatic bacteriuria 3) Review evaluation and management of challenging UTI cases and UTI with community and healthcare-associated multidrug-resistant organisms HIV Update for Primary Care Providers Objectives: 1) Review the current epidemiology of HIV-infection in the US 2) Review HIV prevention recommendations for PCPs, including Pre-Exposure Prophylaxis 3) Understand HIV testing tests and their interpretation 4) Familiarize with antiretroviral therapy drugs and drug- interactions relevant to the PCP Day 3: What’s your Vector, Victor? Tick and Mosquito-Borne Infections in the Outpatient and Emergency Setting Objectives: 1) Review the geographic distribution and epidemiology of the most common vector-borne infections 2) Discuss diagnosis considerations for these patients 3) Provide treatment recommendations for children and adults with vector-borne infections Don’t Hesitate, Vaccinate! Updates to the Immunization Schedule Objectives: 1) Review the ACIP recommendations for vaccine administration, focusing on recent changes to influenza, hepatitis B, varicella; 2) Identify novel strategies to address vaccine hesitancy in the outpatient setting Viral Hepatitis A-E with an Emphasis on C Objectives: 1) Review acute and chronic viral hepatitis syndromes and when to screen for them 2) Participants will be able to interpret laboratory testing for hepatitis B and hepatitis C 3) Review recent advances and challenges in treatment of chronic hepatitis B and C May I Run Something By You?": Infectious Disease Curbsides and Images - A Case-based Discussion Objectives: 1) List common ID questions from PCPs that are not addressed by other topics 2) List endocarditis prophylaxis recommendations 3) Review diagnosis and treatment of latent TB infection 4) Demonstrate images of common and exotic ID conditions Note: Content is subject to change without notice. Please refer to the activity website for the most current information.
Feb 23 - 27, 2020 | CME/SAM 22.00 | USD $1095 | Whistler, British Columbia
Practical Neuroradiology: Excellence Through Evidence and Guidelines is organized by Mayo Clinic and will be held from Feb 23 - 27, 2020 at Four Seasons Resort and Residences Whistler, Whistler, British Columbia, Canada. Intended Audience: Practical Neuroradiology: Excellence Through Evidence and Guidelines is designed for the practicing radiologist whose work involves neuroradiology, or those involved in the neurourological sciences, neurosurgery, neurology, and/or related fields. Accreditation: Mayo Clinic College of Medicine and Science designates this live activity for a maximum of 22 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Self-Assessment Modules (SAMs) SAM credit is under review and will likely be available for this activity in the amount of 22 SAM credits. Course Description: Practical Neuroradiology: Excellence Through Evidence and Guidelines is intended to provide a clinically-relevant discussion of common diseases involving the brain, head/neck, and spine. In addition to the use of case-based imaging reviews to highlight pearls and pitfalls in diagnostic neuroradiology, existing guidelines and recent literature will be discussed in a matter that is germane to the daily practice of evidence-based medicine. Teaching points will be reinforced by integrating self-assessment throughout the course. Course Learning Objectives: Upon conclusion of this program, participants should be able to: • Discuss pediatric spine imaging • Review the staging of head and neck cancer • Describe malformations of cortical development • Discuss the potential impact of artificial intelligence on the practice of radiology • Review the role of imaging in localizing spinal cerebrospinal fluid leaks • Identify causes of conductive hearing loss • Recognize central nervous system infections • Discuss updates in stroke imaging • Describe white matter diseases of the brain • Review intracranial neoplasms (both intra-axial and extra-axial) • Summarize the evidence and technique for lumbar epidural steroid injections • Discuss spinal neoplasms Time: 14:30 - 18:00 p.m
Feb 27 - Mar 01, 2020 | MOC 18.25 | USD $995 | Whistler, British Columbia
10th Annual Whistler Anesthesiology Summit (WAS 2020) is organized by University of British Columbia Continuing Professional Development (UBC CPD) and will be held from Feb 27 - Mar 01, 2020 at The Westin Resort & Spa, Whistler, Whistler, British Columbia, Canada. Target Audience: Anesthesiologists, Anesthetists, FPAs/GPAs, Residents, Students, AAs, Nurse Anesthetists (CRNAs) Accreditation: MOC Section 1 : 18.25 MOC Section 3 : 5.0 Course Overview: Our theme for 2020 is “The Next 10 Years in Anesthesia” where we will explore the latest developments in the delivery of anesthesia care, and what the future holds for the specialty. Don’t miss this special 10th anniversary of the annual Whistler Anesthesiology Summit! Come join us for an exciting program featuring some of the field’s top experts, and learn about the latest science, best practices, and newest innovations in anesthesiology and perioperative medicine. Additional details will be posted as soon as information is available.
Mar 15 - 19, 2020 | USD $1145 | Whistler, British Columbia
Higher-Order Chromatin Architecture in Time and Space (X3) is organized by Keystone Symposia on Molecular and Cellular Biology and will be held from Mar 15 - 19, 2020 at Whistler Conference Centre, Whistler, British Columbia, Canada. Description Mammalian genomes are folded in a hierarchy of compartments, topologically associating domains (TADs), subTADs, and looping interactions. As genome-wide chromatin architecture maps become widely available, the field is shifting focus from mapping to understanding the dynamics of such structures in development, the cell cycle, and on short time scales in single cells. A critical emerging goal will be to unravel the cause and effect relationship between genome folding and functions such as transcription, replication, recombination, and stability/maintenance. There is also a great need to evaluate the organizing principles governing chromatin topology across many biological conditions and genetic perturbations. Moreover, the role for 3D genome misfolding in the onset and progression of a wide range of human disease states remains an area of high interest across multiple disciplines and organ systems. The conference program will also include workshops on: • Leading computational methods to identify biologically relevant patterns in Hi-C data, • New genome mapping and imaging technologies, and • New data resources available through the 4D Nucleome consortium. Finally, we will conclude with a session devoted to novel tools for imaging and engineering the 3D genome. Overall, the 2020 Keystone meeting is meant to highlight new frontiers across disciplines in tackling the dynamics and functional roles of the 3D genome in cellular functions across time and space in development and disease. Additional details will be posted as soon as they are available.
Mar 15 - 19, 2020 | USD $1145 | Whistler, British Columbia
Skirting Mendel: Non-Classical Mechanisms of Phenotypic Variation, Inheritance and Disease (X4) is organized by Keystone Symposia on Molecular and Cellular Biology and will be held from Mar 15 - 19, 2020 at Whistler Conference Centre, Whistler, British Columbia, Canada. Description The meeting aims to highlight the exciting recent developments on our understanding of mechanisms that control non-genetic phenotypic variation. Referred to also as ‘plasticity’, ‘incomplete penetrance’ or ‘noise’, these processes can impose dramatic shifts upon simple and complex genetic traits. Popularized examples include inter- / trans-generational reprogramming paradigms, twin disease discordance, polyphenism in insects (eg. queen and worker bee), evolutionary capacitance, as well as bi-stability in transcriptional and biological networks. The impact of phenotypic plasticity extends from transcriptional control to population dynamics, and evolution. Through impacts on patient responsiveness and variable disease susceptibility, they provide the foundation of a modern personalized medicine. We will bring together geneticists, chromatin biologists, (epi)genomicists, developmental biologists, mathematicians, physiologists and a growing community of clinical scientists, all interested in the molecular mechanisms that establish, buffer and control phenotypic variation. This meeting aims for the first time to bring these diverse disciplines together and catalyze understanding of trait and disease heterogeneity. Key sessions will include: Stochasticity, multi-stable systems and canalization; Inter -/ trans-generational mechanisms; Repeats and the non-coding genome; the genetics of epigenetics; as well as germline and early embryo chromatin dynamics. Additional details will be posted as soon as they are available.
Mar 16 - 18, 2020 | Mainpro+ 36.00 | CAD $895 | Whistler, British Columbia
CBT Canada supratentorial medicine - CBT Whistler is organized by Cognitive Behavior Therapy (CBT) Canada and will be held from Mar 16 - 18, 2020 at Fairmont Chateau Whistler, Whistler, British Columbia, Canada. Accreditation: The 12.0 hour workshop is the acclaimed "triple strength" CBT for Depression module, accredited for 36.0 Mainpro+ credits by the College of Family Physicians of Canada. Topics: General interest topics covered include procrastination, perfectionism, rumination, self-criticism, self-handicapping, letting go of the past, decision-making, and evidence-based marital enrichment. Additional details will be posted as soon as they are available.
Mar 22 - 26, 2020 | USD $1145 | Whistler, British Columbia
Advances in Cancer Immunotherapy (C4) is organized by Keystone Symposia on Molecular and Cellular Biology and will be held from Mar 22 - 26, 2020 at Fairmont Chateau Whistler, Whistler, British Columbia, Canada. Description Significance Cancer immunotherapy by blocking immune inhibitory checkpoints or engineering T cells for adoptive cell transfer is providing an unprecedented level of long-term antitumor activity in patients with several metastatic cancers. However the majority of patients with advanced cancers still do not experience sustained clinical benefit from immunotherapy. Understanding the mechanistic basis of response and resistance to these therapies and how therapeutic approaches could best be combined will be essential to continue progress. The largest human experiment is currently being conducted with over 900 agents and combinations. Understanding the results to date with what is working and what is not will be important to refine our understanding of immunity in patients with cancer. • What is the rationale for the multiple IO combinations being tested in the clinic? • How do cancers adapt and resist T cell attack? • New approaches to genetically engineer a cancer-fighting immune system. • Can we understand the tumor microenviroment to result in new avenues to treat cancer? • How do T cells react to antigen, gain effector mechanisms and gain memory to fight cancer long term? • Molecular understanding of ‘hot’ and ‘cold’ tumors. • Mechanisms to convert cold tumors to immune responsive tumors. • How to optimally select combination partners for cancer immunotherapies. • Assessment of what has worked and worked and what has not worked in patients. Innovation • Analyses of patient-derived samples provides information on adaptive an genetic resistance mechanisms to immunotherapy. • New methodologies result in higher resolution and multiparametic analyses of how the immune system attacks cancer. • Integration of high throughput data will provide a more comprehensive understanding of cancer and the immune system. • Novel chimeric receptors and gene editing approaches can better engineer T cells against cancer. • Knowledge on what limits checkpoint blockade immunotherapy provides means to combine with other therapies. • Knowledge of current state of outcomes to various agents and combinations in the clinic.
May 17 - 21, 2020 | USD $1145 | Whistler, British Columbia
Mitochondrial Biochemistry in Health and Disease (Z1) is organized by Keystone Symposia on Molecular and Cellular Biology and will be held from May 17 - 21, 2020 at Whistler Conference Centre, Whistler, British Columbia, Canada. Description Mitochondria are iconic structures in cell biology and have long been appreciated as centerpieces of bioenergetics. However, many features of these organelles remain remarkably obscure, ranging from the basic functions of orphan mitochondrial proteins to the nature of acute regulation of mitochondrial activities and the mechanisms that these organelles use to communicate with the rest of the cell. Our weak grasp on these and other core features of mitochondria underlie our poor ability to address mitochondrial dysfunction therapeutically. This meeting will bring together world leaders in diverse areas of mitochondrial biology to discuss new tools and emerging themes in the field, including the use of multi-layered omics analyses and systems biology to functionalize new disease-related proteins, the use of metabolomics and ribosome profiling methods to elucidate the orchestration of the many distinct events required for mitochondrial biogenesis, and the application of novel imaging and labeling approaches to reveal the nature of mitochondrial dynamics and inter-organellar contacts. Additional details will be posted as soon as they are available.
May 17 - 21, 2020 | USD $1145 | Whistler, British Columbia
Adaptive ROS Signaling in Physiology and Disease (Z2) is organized by Keystone Symposia on Molecular and Cellular Biology and will be held from May 17 - 21, 2020 at Whistler Conference Centre, Whistler, British Columbia, Canada. Description Reactive oxygen species (ROS) are widely considered unwanted by-products of mitochondrial metabolism and physiology, which can damage proteins, lipids and DNA. Accordingly and for many decades, ROS have been linked to the initiation and progression of cancer, diabetes, neurodegeneration, systemic aging, and others. Emerging evidence suggests that ROS at physiological levels may rather act as short-lived signaling molecules linking mitochondrial activity to nuclear transcription and subsequently cellular homeostasis, a process called retrograde response. The meeting will provide a forum for new and paradigm-shifting ideas and an opportunity for new investigators to enter the field. These include ROS-sensitive transcriptional effects in the nucleus, conformational changes following cysteine oxidation within signaling molecules, ROS-mediated host-pathogen interactions, limitations of cancer growth by ROS, ROS-induced autophagy, mitophagy and proteostasis, as well as ROS-mediated effects of forkhead-, NRF2 and sirtuin-signaling. Lastly and with a clinical/epidemiological perspective, the role of ROS in human disease and ROS-inducing compounds based will be addressed. Given the recently established roles of ROS in diverge research areas like aging, cancer biology, immunity, metabolism, mitochondria, and others this meeting would converge highly interdisciplinary scientific interests from both academia and industry in an unprecedented manner. Additional details will be posted as soon as they are available.